Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Neurotrope Inc.

Tech Transfer Roundup: Mustang, Nationwide Children’s Hospital Collaborate In Pediatric Glioblastoma

Partnership will test Mustang’s MB-101 with a second-generation oncolytic HSV-1 virus for potential in treating brain cancer. Canadian biotech launched by CCAB to fight the same cancer.

Companies Deals

Tech Transfer Roundup: GE Healthcare, Vanderbilt Partner To Optimize Precision Cancer Immunotherapy

Five-year collaboration will analyze data from thousands of cancer patients to optimize immunotherapy treatment and develop PET imaging tracers to stratify clinical trial participants. Also, MD Anderson starts 2019 with three new agreements.

Deals Commercial

Pipeline Watch: Top-line Phase III Results For KX2-391, Dasotraline And Brigatinib

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Appointments: Neurotrope, Concert, Lannett, Peregrine, Allergan, Amneal, Acticor, Alliance Pharma

The latest biopharma industry appointments include new CEOs at Neurotrope, Lannett, Amneal and Peregrine Pharmaceuticals, a new CFO at Concert Pharmaceuticals, a new EVP of global operations at Allergan, a new CMO at Acticor, and a US country manager for Alliance Pharma.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Neurotrope BioScience Inc.
  • Neurotrope Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neurotrope Inc.
  • Senior Management
  • Susanne Wilke, PhD, CEO
    Robert Weinstein, CFO
    Daniel Alkon, MD, Pres. & CSO
    Michael Ciraolo, PhD, General counsel & COO
  • Contact Info
  • Neurotrope Inc.
    Phone: (973) 242-0005
    50 Park Place
    14th Floor
    Newark, NJ 07102
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register